Savara Inc. Files Q1 2025 10-Q Report
Ticker: SVRA · Form: 10-Q · Filed: May 13, 2025 · CIK: 1160308
| Field | Detail |
|---|---|
| Company | Savara Inc (SVRA) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Savara Inc. 10-Q filed. Q1 2025 financials out.
AI Summary
Savara Inc. filed its 10-Q for the period ending March 31, 2025, reporting on its financial activities. The company, formerly known as Mast Therapeutics, Inc., is involved in the pharmaceutical preparations industry. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with an update on Savara Inc.'s financial health and operational status for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Savara Inc. is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter covered by the report.)
- 2025-05-13 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
- 1231 — Fiscal Year End (Specifies the end date of Savara Inc.'s fiscal year.)
Key Players & Entities
- Savara Inc. (company) — Filer of the 10-Q report
- Mast Therapeutics, Inc. (company) — Former name of Savara Inc.
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date of the report
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Savara Inc.?
Savara Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
When was this 10-Q report filed with the SEC?
This 10-Q report was filed on May 13, 2025.
Has Savara Inc. always been known by its current name?
No, Savara Inc. was formerly known as Mast Therapeutics, Inc., with a name change date of March 12, 2013.
What is the company's fiscal year end?
Savara Inc.'s fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Savara Inc (SVRA).